Pharmaceutical Continuous Manufacturing
Pharmaceuticals

9.8% Global CAGR for Pharmaceutical Continuous Manufacturing Market to achieve US$ 3,064.38 Mn by 2027

GEA Group and Thermo Fisher Scientific, Inc. – Notable Market Players in Pharmaceutical Continuous Manufacturing Market

Continuous manufacturing in the pharmaceutical industry is a result of advancements in technology with respect to the production techniques. In the past years, the traditional method of batch manufacturing was followed in the pharmaceutical industry. However, the development in technology has accelerated mass production with improved quality, and it has addressed the many primary causes such as the recall of drugs and recalls. The pharmaceutical industry has recently begun to acknowledge the continuous manufacturing as an option to improve and sustain manufacturing operations.

Market leaders operating in the market have undertaken various inorganic growth strategies in the pharmaceutical continuous manufacturing market. The pharmaceutical continuous manufacturing market majorly consists of the players such as GEA Group, Coperion GmbH, Gericke AG, Glatt GmbH, Hosokawa Micron Group, Munson Machinery Co. Inc., Powrex Corp, Thermo Fisher Scientific Inc., Freund-vector Corporation, Fette Compacting, Alexanderwerk, LEISTRITZ AG, KORSCH AG, ACG, Cadmach Machinery Co. Pvt. Ltd., and Hovione en Aesica. Inorganic growth strategies witnessed in the market such as partnerships, collaboration, and mergers & acquisitions have paved way for expansion of business and customer base of market players

Below is the list of the growth strategies done by the players operating in the pharmaceutical continuous manufacturing market:

Year

News

May, 2019

Thermo Fisher Scientific has acquired a drug substance-manufacturing site in Cork, Ireland, from GlaxoSmithKline to meet customer demand for the development and commercial manufacturing of complex active pharmaceutical ingredients (APIs).

November, 2017

Fette Compacting has entered into a partnership with Glatt to develop integrated solutions for the continuous manufacturing of oral solid dosage (OSD) forms.

September, 2017

GEA and the Research Center for Pharmaceutical Engineering GmbH (RCPE) have entered into a collaboration to facilitate the industrial implementation of continuous manufacturing technologies.